Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer

NCT04739670 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Triple Negative Breast Cancer

Interventions

DRUG: Atezolizumab
DRUG: Bevacizumab
DRUG: Gemcitabine
DRUG: Carboplatin

Sponsor

Peter MacCallum Cancer Centre, Australia